Nectar Lifesciences Balance Sheet Health
Financial Health criteria checks 4/6
Nectar Lifesciences has a total shareholder equity of ₹10.7B and total debt of ₹6.8B, which brings its debt-to-equity ratio to 63.8%. Its total assets and total liabilities are ₹21.4B and ₹10.8B respectively. Nectar Lifesciences's EBIT is ₹618.2M making its interest coverage ratio 0.7. It has cash and short-term investments of ₹203.5M.
Key information
63.8%
Debt to equity ratio
₹6.81b
Debt
Interest coverage ratio | 0.7x |
Cash | ₹203.51m |
Equity | ₹10.67b |
Total liabilities | ₹10.75b |
Total assets | ₹21.43b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 532649's short term assets (₹12.1B) exceed its short term liabilities (₹8.8B).
Long Term Liabilities: 532649's short term assets (₹12.1B) exceed its long term liabilities (₹1.9B).
Debt to Equity History and Analysis
Debt Level: 532649's net debt to equity ratio (61.9%) is considered high.
Reducing Debt: 532649's debt to equity ratio has reduced from 83.8% to 63.8% over the past 5 years.
Debt Coverage: 532649's debt is well covered by operating cash flow (25.9%).
Interest Coverage: 532649's interest payments on its debt are not well covered by EBIT (0.7x coverage).